Skip to main content
Clinical Trials/IRCT2016010825903N1
IRCT2016010825903N1
Completed
Phase 3

Role of hemoglobin and the effect of it’s correction on pregnancy outcome in minor and intermedia thalasemia patients

Vice chancellor For Research Of Ahvaz Jundishapur University of Medical Sciences0 sites36 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Condition 1: thalassaemia. Condition 2: Pregnancy.
Sponsor
Vice chancellor For Research Of Ahvaz Jundishapur University of Medical Sciences
Enrollment
36
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Vice chancellor For Research Of Ahvaz Jundishapur University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Inclusion Criteria: thalassemia minor and intermedia women and pregnant
  • With hemoglobin over 8\.5; Bearing a singleton baby; Patient with ages: 20\-35 years old.

Exclusion Criteria

  • Patients with metabolic diseases such as cushing syndrome, Hypothyroidism and hyperthyroidism; chronic diseases such as rheumatic disease, autoimmune and antiphospholipid syndrome.

Outcomes

Primary Outcomes

Not specified

Similar Trials